These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 14715700)
1. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. Axelrad TW; Deo DD; Ottino P; Van Kirk J; Bazan NG; Bazan HE; Hunt JD FASEB J; 2004 Mar; 18(3):568-70. PubMed ID: 14715700 [TBL] [Abstract][Full Text] [Related]
2. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Ottino P; He J; Axelrad TW; Bazan HE Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Ma X; Ottino P; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102 [TBL] [Abstract][Full Text] [Related]
4. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737 [TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Tao Y; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905 [TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones. Barletta E; Mugnai G; Ruggieri S Biol Chem; 2002 Jan; 383(1):189-97. PubMed ID: 11928813 [TBL] [Abstract][Full Text] [Related]
7. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378 [TBL] [Abstract][Full Text] [Related]
10. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050 [TBL] [Abstract][Full Text] [Related]
11. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039 [TBL] [Abstract][Full Text] [Related]
12. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. Karagiannis ED; Popel AS J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020 [TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
14. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin. Dahi S; Lee JG; Lovett DH; Sarkar R J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603 [TBL] [Abstract][Full Text] [Related]
15. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Jo M; Thomas LE; Wheeler SE; Curry TE Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206 [TBL] [Abstract][Full Text] [Related]
16. Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells. Deo DD; Bazan NG; Hunt JD J Biol Chem; 2004 Jan; 279(5):3497-508. PubMed ID: 14617636 [TBL] [Abstract][Full Text] [Related]
17. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y; Yeon J; Kim HJ; Lee ST Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells. Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]